In:
Applied Biological Chemistry, Springer Science and Business Media LLC, Vol. 66, No. 1 ( 2023-06-17)
Abstract:
Ten benzimidazole chalcone derivatives were synthesized, and their monoamine oxidase (MAO) inhibitory activity was evaluated. Most compounds showed higher inhibitory activity against MAO-B than MAO-A. Compound BCH2 exhibited an IC 50 value of 0.80 μM, thereby showing the most potent inhibition amongst all. In addition, BCH2 showed the highest MAO-B selectivity index (SI) with an SI value of 44.11 compared to MAO-A. Among the substituents, the halogen group showed the best MAO-B inhibition, and the ortho -position of the B ring showed better inhibitory activity than the para -site. In comparison with ortho -substituents, the inhibitory activity increased in the order, -Cl 〉 -Br 〉 -F 〉 -H. BCH2 was found to be a competitive inhibitor of the enzyme with optimum inhibition kinetics, where K i was found to be 0.25 ± 0.014 μM. In the reversibility experiment, BCH2 showed a recovery pattern after MAO-B inhibition, similar to that of lazabemide. Thus, BCH2 is a potent, reversible, and selective MAO-B inhibitor and has been suggested as a candidate for the treatment of neurological disorders.
Type of Medium:
Online Resource
ISSN:
2468-0842
DOI:
10.1186/s13765-023-00795-1
Language:
English
Publisher:
Springer Science and Business Media LLC
Publication Date:
2023
detail.hit.zdb_id:
2846955-0
Permalink